Stock KALV KALVISTA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart KalVista Pharmaceuticals, Inc.

Equities

KALV

US4834971032

Real-time Estimate Cboe BZX
Other stock markets
 09:57:07 2024-07-01 EDT 		5-day change 1st Jan Change
11.56 USD -1.83% Intraday chart for KalVista Pharmaceuticals, Inc. 0.00% -4.33%
06-27 KalVista Starts Hereditary Angioedema Trial in Pediatric Patients MT
06-27 KalVista Pharmaceuticals, Inc. Initiates KONFident-KID Trial for On-Demand Treatment of Hereditary Angioedema Attacks with Sebetralstat in Children Aged 2 to 11 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
KALVISTA PHARMACEUTICALS, INC. Stock KalVista Pharmaceuticals, Inc.
 497M - - - - -
CSL LIMITED Stock CSL Limited
 95.18B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
 37.55B
BIOGEN INC. Stock Biogen Inc.
 33.75B
UCB Stock UCB
 28.2B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
 15.63B
  1. Stock Market
  2. Equities
  3. KALV Stock
  4. Charts KalVista Pharmaceuticals, Inc.
  5. Sector Chart